Abstract
New drugs are introduced to the market every year and each individual drug represents a privileged structure for its biological target. In addition, these new chemical entities (NCEs) not only provide insights into molecular recognition, but also serve as drug-like leads for designing future new drugs. To these ends, this review covers the syntheses of 22 NCEs marketed in 2005.
Keywords: Synthesis, new drug, new chemical entities, medicine, therapeutic agents
Mini-Reviews in Medicinal Chemistry
Title: Synthetic Approaches to the 2005 New Drugs
Volume: 7 Issue: 4
Author(s): Subas M. Sakya, Jin Li and Kevin K.-C. Liu
Affiliation:
Keywords: Synthesis, new drug, new chemical entities, medicine, therapeutic agents
Abstract: New drugs are introduced to the market every year and each individual drug represents a privileged structure for its biological target. In addition, these new chemical entities (NCEs) not only provide insights into molecular recognition, but also serve as drug-like leads for designing future new drugs. To these ends, this review covers the syntheses of 22 NCEs marketed in 2005.
Export Options
About this article
Cite this article as:
Sakya M. Subas, Li Jin and Liu K.-C. Kevin, Synthetic Approaches to the 2005 New Drugs, Mini-Reviews in Medicinal Chemistry 2007; 7 (4) . https://dx.doi.org/10.2174/138955707780363800
DOI https://dx.doi.org/10.2174/138955707780363800 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers